News
It is high time API sector re-devises strategies to overcome the ...
pharmabiz.com
[pharmabiz.com] - In such a gloomy scenario, it is high time pharma companies particularly the active pharma ingredient (API) sector re-devises manufacturing strategies to look at different dosage forms, adopt nanotechnology and opt for genomic drugs, Anjan K Roy
OSCL enters into API segment with the acquisition of LASA Lab
pharmabiz.com
[pharmabiz.com] integration of some of the key intermediates which are currently being manufactured by OSCL. The Companies product portfolio comprises of 10 products in the veterinary anthelmentic segment, mainly benzimidazoles and other active pharma ingredients.
Omkar Chemicals to invest Rs 100 crore in Chiplun facility
economictimes.indiatimes.com
[Economic Times] - Currently, our product portfolio comprises 10 products in the veterinary anthelmentic segment, mainly benzimidazoles and other active pharma ingredients, Herlekar said. OSCL has diversified business interests having a major presence in pharma
Omkar Speciality Chemicals forays into Pharma Business
www.equitybulls.com
[Equity Bulls] - Currently, the product portfolio in this division comprises 10 products in the veterinary anthelmentics segment, mainly Benzimidazoles and other active pharma ingredients. The Omkar Speciality Chemicals Ltd stock closed the day at Rs
sorted by relevance / date